PERF NYSE Week ended 31 Jul 2026

Weekly Investor Report

Perfect Corp. · Technology · Software - Application

Open interactive chart View report data
Latest close 1.92 USD
-0.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 15.5% above the Trend Line and sits at 73.9% of its 52-week range. The latest completed week returned -0.5%, after a 13.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 2d.

Setup score 62 out of 100
Latest Close 1.92 USD 31 Jul 2026
1W Return -0.5% latest completed week
4W Return 13.6% short-term follow-through
12W Return 13.6% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.5% Latest completed week; four-week move 13.6%. Indicator stack 27/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 55/100 54 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 15.5% above the Trend Line and sits at 73.9% of its 52-week range. The latest completed week returned -0.5%, after a 13.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5312-week average 0.38

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.53Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 13.6% over four weeks, 13.6% over 12 weeks, and 3.2% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-0.5%
4W13.6%
12W13.6%
26W23.1%
52W3.2%
Active trend streak5 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.67Latest activity-pressure read.
Pressure change328.6%Four-week change in activity pressure.
Leadership0.33Latest relative-leadership reading.
RS change102.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength74/100Blend of value, momentum, and quality. Underlying universe rank 27; rank 1 is best.
Value77/100Relative valuation strength. Underlying universe rank 24; rank 1 is best.
Quality79/100Profitability and accounting quality. Underlying universe rank 22; rank 1 is best.
Momentum13/100Medium-term price momentum. Underlying universe rank 88; rank 1 is best.
Growth30/100Revenue and earnings growth. Underlying universe rank 71; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework80/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
41.8x
Price divided by trailing earnings.
Price / sales
2.8x
Market value relative to trailing revenue.
EV / EBITDA
10.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
17.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
78.4%
Gross profit retained from each unit of revenue.
Operating margin
8.6%
Operating profit retained from revenue.
Free-cash-flow margin
19.2%
Free cash flow generated from revenue.
Return on invested capital
13.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
14.8%
Latest one-year revenue growth.
EPS growth
-29.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-3.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-16.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 54 relevant articles.

16 positive · 34 neutral · 4 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.1%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 269 weeks finished lower.
Best week+21.3%Week of 20 Mar.
Worst week-12.2%Week of 6 Feb.
Latest week-0.5%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains9
Flat weeks3
Modest losses6
Sharp losses3
Recent vol3.9%13-week weekly-return volatility.
Base vol5.6%52-week weekly-return volatility.
Up/down split23/20Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape56/100

Trend, activity pressure, participation, and risk combine to a 56/100 tape read.

 Indicator analysis53/100

Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 2/12.

Activity pressure 0.53; No reversal markers Factors62/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 66; Small Cap Core rank 75 SVQF80/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 199.5 of 1013 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment55/100

Weighted news tone is neutral across 54 relevant articles.

Perfect Corp. Revenue Breakdown – NYSE:PERF Insiders50/100

No recent insider transaction evidence is stored.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.92 USD-0.5%1.66 USD2.15 USD1.670.331.5MOn
24 Jul 20261.93 USD0.5%1.66 USD2.16 USD1.291.611.4MOn
17 Jul 20261.92 USD0.0%1.65 USD2.18 USD0.87-0.542.2MOn
10 Jul 20261.92 USD13.6%1.65 USD2.20 USD0.63-3.114.5MOn
3 Jul 20261.69 USD1.8%1.64 USD2.22 USD0.39-14.24219.5KOn
26 Jun 20261.66 USD-1.2%1.64 USD2.24 USD0.57-15.06280.5KOff
19 Jun 20261.68 USD0.0%1.65 USD2.26 USD0.82-16.86327.3KOff
12 Jun 20261.68 USD0.6%1.65 USD2.28 USD0.83-16.78256.7KOff
5 Jun 20261.67 USD-3.5%1.65 USD2.30 USD0.86-17.28565.6KOff
29 May 20261.73 USD0.6%1.66 USD2.32 USD0.86-16.92547.4KOff
22 May 20261.72 USD1.8%1.67 USD2.34 USD0.83-16.69197.7KOff
15 May 20261.69 USD0.0%1.68 USD2.36 USD0.77-17.91420.1KOff
8 May 20261.69 USD-1.2%1.69 USD2.38 USD0.76-18.16552.8KOff
1 May 20261.71 USD3.0%1.69 USD2.40 USD0.70-15.91226.4KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.